Parkinson’s Disease Awareness Month.
Fiscal committee
No
Current location
Chaptered
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Overview
This resolution designates April 2026 as Parkinson’s Disease Awareness Month in California. It highlights the significant impact of Parkinson’s disease on individuals, families, and the state’s healthcare system, citing its prevalence, economic costs, and ongoing research efforts. The resolution recognizes the work of researchers, caregivers, and healthcare providers in improving the lives of those affected by the disease and emphasizes the importance of continued investment in research and data collection.
Key provisions
- Proclaims April 2026 as Parkinson’s Disease Awareness Month in California.
- Recognizes the significant impact of Parkinson’s disease on individuals and families.
- Acknowledges the economic costs associated with the disease, including state and federal expenditures.
- Highlights the role of the California Parkinson’s Disease Registry in collecting patient data.
- Recognizes advancements in Parkinson’s disease research, including the validation of a biomarker by the Michael J. Fox Foundation.
- Emphasizes the need for increased research, education, and community support services.
- Calls for continued public and private investment in biomedical research.
- Recognizes California’s leadership in neuroscience innovation and clinical trials.
Who is affected
- Individuals with Parkinson’s disease and their families
- Caregivers of individuals with Parkinson’s disease
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours